高级检索
当前位置: 首页 > 详情页

MicroRNA-34a promoting apoptosis of human lens epithelial cells through down-regulation of B-cell lymphoma-2 and silent information regulator.

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

机构: [1]Department of Ophthalmology, Ruikang Hospital affiliatedto Guangxi University of Chinese Medicine, Nanning530000, Guangxi Zhuang Autonomous Region, China [2]Department of Ophthalmology, Guangdong General Hospitaland Guangdong Academy of Medical Sciences, Guangzhou510000, Guangdong Province, China [3]Zhengzhou Aier Eye Hospital, Aier School ofOphthalmology, Central South University, Zhengzhou450000, Henan Province, China
出处:
ISSN:

关键词: human lens epithelial cells microRNA-34a apoptosis

摘要:
To investigate the role of microRNA-34a (miR-34a) in the induction of apoptosis of human lens epithelial (HLE-B3) cells. The apoptosis of HLE-B3 cells was detected by Annexin V-PE apoptosis detection kit after the treatment with 200 µmol/L H2O2 for 24h and lentiviral miR-34a vector transfection. The expression of miR-34a in the cells was quantified by quantitative real time polymerase chain reaction (qRT-PCR) in response to H2O2 exposure and the vector transfection. The effects of overexpression of miR-34a on the expression of B-cell lymphoma-2 (Bcl-2) and silent information regulator 1 (SIRT1) was determined by qRT-PCR and Western blot. The expression of miR-34a was up-regulated by the treatment of H2O2 in HLE-B3 cells. The increased expression of miR-34a is accompanied with the cell apoptosis. Consistence with the H2O2 exposure, ectopic overexpression of miR-34a in HLE-B3 cells promoted cells apoptosis. Importantly the anti-apoptosis factors Bcl-2 and SIRT1 were reduced significantly by up-regulation of miR-34a in HLE-B3 cells. MiR-34a promotes the apoptosis of HLE-B3 cells by down-regulating Bcl-2 and SIRT1, suggesting that miR-34a may involve in the pathogenesis of cataract formation and targeting miR-34a may be a potentially therapeutic approach for treatment of cataract.

语种:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2016]版:
大类 | 4 区 医学
小类 | 4 区 眼科学
最新[2025]版:
大类 | 4 区 医学
小类 | 3 区 眼科学
JCR分区:
出版当年[2015]版:
Q4 OPHTHALMOLOGY
最新[2023]版:
Q2 OPHTHALMOLOGY

影响因子: 最新[2023版] 最新五年平均 出版当年[2015版] 出版当年五年平均 出版前一年[2014版] 出版后一年[2016版]

第一作者:
第一作者机构: [1]Department of Ophthalmology, Ruikang Hospital affiliatedto Guangxi University of Chinese Medicine, Nanning530000, Guangxi Zhuang Autonomous Region, China [2]Department of Ophthalmology, Guangdong General Hospitaland Guangdong Academy of Medical Sciences, Guangzhou510000, Guangdong Province, China
通讯作者:
通讯机构: [2]Department of Ophthalmology, Guangdong General Hospitaland Guangdong Academy of Medical Sciences, Guangzhou510000, Guangdong Province, China [3]Zhengzhou Aier Eye Hospital, Aier School ofOphthalmology, Central South University, Zhengzhou450000, Henan Province, China [*1]Department of Ophthalmology, Guangdong General Hospital and Guangdong Academy of Medical Sciences, Guangzhou 510000,Guangdong Province, China.
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:87470 今日访问量:2 总访问量:721 更新日期:2025-04-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 云南省第一人民医院 技术支持:重庆聚合科技有限公司 地址:云南省昆明市西山区金碧路157号